Company patents
Lensar, Inc.
Lensar, Inc. demonstrates a primary focus on medical devices, with Implants & Prosthetics accounting for 78.4% of its portfolio and Medical Diagnostics & Surgery representing 56.9%, the latter showing rapid growth of +71.4% in 2025 before a partial year decline in 2026. Surprisingly, the company has also ventured into Business Methods & Fintech, which emerged with 3 patents in 2025, suggesting a diversification beyond its core medical technology.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
51 US filings (since 2023) · 5 categories · 6 themes
Integrated systems and specialized instruments for performing delicate surgical procedures on the eye, often involving the delivery, manipulation, or monitoring of ophthalmic implants.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Implantable devices that deliver electrical, optical, or other forms of energy to stimulate tissues or nerves, or sense physiological parameters for therapeutic purposes.
Systems that use user data, preferences, and machine learning to generate tailored advice, product recommendations, goal-setting plans, or contextual information for individuals across different domains.
Methods and apparatus for improving the visual fidelity, resolution, or compression efficiency of video signals, often through advanced processing, up-scaling, or neural network-based filters.
Patents
Showing 1-10 of 79